Cambridge Oncology Seminar Series
This Seminar series is being developed to cover clinical, laboratory and translational aspects of cancer.
It is being organised jointly by members of the Cambridge Research Institute, the Addenbrooke's Hospital Clinical, Medical and Surgical Oncology departments and the Hutchison/MRC Research Centre.
In addition to external speakers, group leaders from each of the Departments will give presentations, with either one or two speakers per session.
The talks are open to all interested persons from the University of Cambridge, Cancer Research UK and Addenbrooke's Hospital. Members of the local pharma and biotechnology companies are also welcome to attend by prior arrangement with Laura Blackburn.
All talks take place on Tuesdays at 12 noon in the Sackler Lecture Theatre, Level 7, CIMR, or in the Cambridge Research Institute Lecture Theatre.
| 14 September 2010 Venue: CRI Lecture Theatre |
Interactions of Epidermal Growth Factor Receptor Inhibition with DNA damage in the treatment of gastrointestinal cancer Daniel Hochhauser University College London |
| 21 September 2010 Venue: CRI Lecture Theatre |
Pathway analysis of glioblastoma tissue after pre-operative treatment with the EGFR tyrosine kinase inhibitor gefitinib - a phase-0 trial Monika Hegi University Hospital (CHUV), Lausanne, Switzerland |
| 28 September 2010 Venue: CRI Lecture Theatre |
EGFR mutation screening in NSCLC David Gonzalez de Castro Institute of Cancer Research |
| 5 October 2010 Venue: CRI Lecture Theatre |
Title to be confirmed Speaker to be announced |
| 12 October 2010 Venue: CRI Lecture Theatre |
Title to be confirmed Kevin Brindle Cambridge Research Institute |
| 19 October 2010 Venue: CRI Lecture Theatre |
Title to be confirmed Sarah Jefferies Addenbrooke's Hospital |
| 26 October 2010 Venue: CRI Lecture Theatre |
Chromosome translocations and tumour suppressors in breast cancer Paul Edwards Hutchison-MRC Research Centre |
| 2 November 2010 Venue: Sackler Lecture Theatre, CIMR, Level 7 |
Title to be confirmed Speaker to be announced |
| 23 November 2010 Venue: CRI Lecture Theatre |
Title to be confirmed Colin Watts Cambridge Centre for Brain Repair |
| 30 November 2010 Venue: CRI Lecture Theatre |
Susceptibility to cancer - what's new? Doug Easton Strangeways Research Laboratory |
| 7 December 2010 Venue: Sackler Lecture Theatre, CIMR, Level 7 |
Title to be confirmed Speaker to be announced |
| 14 December 2010 Venue: CRI Lecture Theatre |
Title to be confirmed Tim Eisen University of Cambridge Department of Oncology and Addenbrooke's Hospital |
| 11 January 2011 Venue: CRI Lecture Theatre |
Title to be confirmed Chris Nutting Royal Marsden Hospital |
| 18 January 2011 Venue: CRI Lecture Theatre |
Title to be confirmed Michael Schneider Imperial College London |
| 25 January 2011 Venue: Sackler Lecture Theatre, CIMR, Level 7 |
Title to be confirmed Brian Huntly Addenbrooke's Hospital |
| 8 February 2011 Venue: CRI Lecture Theatre |
Title to be confirmed Hilary Calvert UCL Cancer Institute |
| 22 February 2011 Venue: CRI Lecture Theatre |
Title to be confirmed David Gilligan Addenbrooke's Hospital |
| 8 March 2011 Venue: CRI Lecture Theatre |
FGF-2, S6 kinase 2 and chemo-resistance in lung cancer Michael Seckl Imperial College London and Charing Cross Hospital |
| 26 April 2011 Venue: CRI Lecture Theatre |
Title to be confirmed Vincent Gnanapragasam Hutchison-MRC Research Centre and Addenbrooke's Hospital |
